Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Jul;6(3):143-5.

Editorial: Utilization of Hybrid PET/MR in Neuroimaging

Masoud Tahmasian  1 , Carsten Eggers  2 , Valentin Riedl  3 , Christian Sorg  4 , Alexander Drzezga  5
Affiliations

Editorial: Utilization of Hybrid PET/MR in Neuroimaging

Masoud Tahmasian et al. Basic Clin Neurosci. 2015 Jul.
No abstract available

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Potential applications of “one-stop shop” MR/PET imaging protocol in diagnosis of Alzheimer disease. This figure was originally published in JNM. Drzezga A. Barthel et al., 2014. Journal of Nuclear Medicine. 2014; 55 (Supplement 2): 47S–55S. © by the Society of Nuclear Medicine and Molecular Imaging, Inc.
See this image and copyright information in PMC

References

    1. Catana C., Benner T., van der Kouwe A., Byars L., Hamm M., Chonde D. B., Michel C. J., El Fakhri G., Schmand M., Sorensen A. G. (2011). “ MRI-assisted PET motion correction for neurologic studies in an integrated MR-PET scanner.” Journal of Nuclear Medicine, 52(1), 154– 161. - PMC - PubMed
    1. Delso G., Furst S., Jakoby B., Ladebeck R., Ganter C., Nekolla S. G., Schwaiger M., Ziegler S. I. (2011). “ Performance measurements of the Siemens mMR integrated whole-body PET/MR scanner.” Journal of Nuclear Medicine, 52(12), 1914– 1922. - PubMed
    1. Drzezga A., Souvatzoglou M., Eiber M., Beer A. J., Furst S., Martinez-Moller A., Nekolla S. G., Ziegler S., Ganter C., Rummeny E. J., Schwaiger M. (2012). “ First clinical experience with integrated whole-body PET/MR: comparison to PET/CT in patients with oncologic diagnoses.” Journal of Nuclear Medicine, 53(6), 845– 855. - PubMed
    1. Drzezga A., Barthel H., Minoshima S., Sabri O. (2014). “ Potential clinical applications of PET/MR imaging in neurodegenerative diseases.” Journal of Nuclear Medicine, 55(Supplement 2), 47S– 55S. - PubMed
    1. Eiber M., Martinez-Moller A., Souvatzoglou M., Holzapfel K., Pickhard A., Loffelbein D., Santi I., Rummeny E. J., Ziegler S., Schwaiger M., Nekolla S. G., Beer A. J. (2011). “ Value of a Dixon-based MR/PET attenuation correction sequence for the localization and evaluation of PET-positive lesions.” European Journal of Nuclear Medicine & Molecular Imaging, 38(9), 1691– 1701. - PubMed

LinkOut - more resources